Showing results (41-50 of 106) with videos related to
Sort By:
Pageof 11
The American Journal of Surgical Pathology|April 14, 2012
TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patientsWilliam R Sukov, Jennelle C Hodge, Christine M Lohse, et al.Human Pathology|April 24, 2009
CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinomaWilliam R Sukov, Rhett P Ketterling, Donna J Lager, et al.Cancer Research|May 23, 2013
Lineage relationship of Gleason patterns in Gleason score 7 prostate cancerIrina V Kovtun, John C Cheville, Stephen J Murphy, et al.Human Pathology|March 17, 2016
TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization studyRiyam T Zreik, Jodi M Carter, William R Sukov, et al.Human Pathology|April 17, 2012
A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue typeRondell P Graham, Jennelle C Hodge, Andrew L Folpe, et al.Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.American Journal of Clinical Pathology|July 28, 2018
The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms: An ACLPS Critical ReviewJess F Peterson, Daniel L Van Dyke, Nicole L Hoppman, et al.American Journal of Clinical Pathology|January 29, 2013
Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancerAaron S Mansfield, William R Sukov, Jeanette E Eckel-Passow, et al.Annals of Diagnostic Pathology|August 25, 2020
Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literatureDaniel S Martig, Cynthia M Williamson, Xinjie Xu, et al.Human Pathology|November 24, 2025
Sarcomatoid carcinoma of the prostate - A single institution experience with emphasis on molecular genetic findingsBurak Tekin, Lagnajita Datta, Ramin Zargham, et al.Pageof 11